"New Perspectives of Adaptation to NIV in ALS"
Not Applicable
Completed
- Conditions
- Amyotrophic Lateral Sclerosis (ALS)
- Interventions
- Other: Adaptation and training to Non Invasive Ventilation (NIV)
- Registration Number
- NCT02537132
- Lead Sponsor
- Fondazione Don Carlo Gnocchi Onlus
- Brief Summary
The purpose of this study is to demonstrate that the adaptation to the Non Invasive Ventilation (NIV) at home is not worse when compared with an adaptation performed in inpatient settings.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
- ALS diagnosis according to the criteria of El Escorial;
- Clinical indication to NIV (nocturnal hypoventilation and respiratory muscle weakness confirmed according to the criteria normally accepted);
- No respiratory infection within 3 months
- Severe disability (ALS-FRS <31);
- Age > 18 years;
- The voluntary participation to the Study.
Exclusion Criteria
-- Previous episodes of pneumothorax;
- Comorbid cardiac and / or renal important
- Severe cognitive impairment;
- Refusal of the patient at the time of Informed Consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Home Group Adaptation and training to Non Invasive Ventilation (NIV) Adaptation and training to Non Invasive Ventilation (NIV) (not less than five sessions), at home Outpatient Group Adaptation and training to Non Invasive Ventilation (NIV) Adaptation and training to Non Invasive Ventilation (NIV) (not less than five sessions), at the outpatient clinic
- Primary Outcome Measures
Name Time Method Change from baseline in adherence NIV in ALS patients at baseline, 2 and 4 months as measured by monthly means and standard deviations of hours of use of Non Invasive Ventilation (NIV) Baseline + after 2 and 4 months from the recruitment The primary outcome the time of adherence to NIV defined as actual use of NIV for not less than 150 hours / month.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Michele Vitacca
🇮🇹Lumezzane, Brescia, Italy
Paolo Banfi
🇮🇹Milan, Italy